Fulcrum Therapeutics (FULC) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

FULC is expected to report earnings to fall 4.11% to -33 cents per share on February 27

Fulcrum Therapeutics FULC Stock Earnings Reports

Q4'24

Est.

$-0.34

Q3'24

Beat

by $0.05

Q2'24

Beat

by $1.28

Q1'24

Beat

by $0.01

Q4'23

Beat

by $0.03

The last earnings report on November 13 showed earnings per share of -34 cents, beating the estimate of -40 cents. With 654.33K shares outstanding, the current market capitalization sits at 207.17M.

View a ticker or compare two or three

Compare

FULC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For FULC
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for FULC (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a clinical-stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

26 Landsdowne Street

Phone

+1 617 651-8851

Employees

Web

https://www.fulcrumtx.com